| Drug Name | Target | ATC Codes | Indications |
|---|---|---|---|
| Motexafin lutetium | Investigated for use/treatment in brain cancer, breast cancer, cervical dysplasia/cancer, prostate cancer, cancer/tumors (unspecified), coronary artery disease, macular degeneration, and peripheral vascular disease. |